Abstract:Background: Valvular heart disease (VHD) is a major precipitating factor of atrial fibrillation (AF) that contributes to decreased cardiac function, heart failure, and stroke. Stroke induced by VHD combined with atrial fibrillation (AF-VHD) is a much more serious condition in comparison to VHD alone. The aim of this study was to explore the molecular mechanism governing VHD progression and to provide candidate treatment targets for AF-VHD. Methods: Four public mRNA microarray datasets were downloaded and differentially expressed genes (DEGs) screening was performed. Weighted gene correlation network analysis was carried out to detect key modules and explore their relationships and disease status. Candidate hub signature genes were then screened within the key module using machine learning methods. The receiver operating characteristic curve and nomogram model analysis were used to determine the potential clinical significance of the hub genes. Subsequently, target gene protein levels in independent human atrial tissue samples were detected using western blotting. Specific expression analysis of the hub genes in the tissue and cell samples was performed using single-cell sequencing analysis in the Human Protein Atlas tool. Results: A total of 819 common DEGs in combined datasets were screened. Fourteen modules were identified using the cut tree dynamic function. The cyan and purple modules were considered the most clinically significant for AF-VHD. Then, 25 hub genes in the cyan and purple modules were selected for further analysis. The pathways related to dilated cardiomyopathy, hypertrophic cardiomyopathy, and heart contraction were concentrated in the purple and cyan modules of the AF-VHD. Genes of importance (CSRP3, MCOLN3, SLC25A5, and FIBP) were then identified based on machine learning. Of these, CSRP3 had a potential clinical significance and was specifically expressed in the heart tissue. Conclusions: The identified genes may play critical roles in the pathophysiological process of AF-VHD, providing new insights into VHD development to AF and helping to determine potential biomarkers and therapeutic targets for treating AF-VHD.

Screening of Molecular Biomarkers Associated with Heart Failure Derived from Arrhythmogenic Right Ventricular Cardiomyopathy

Identification of Candidate Biomarkers in Peripheral Blood for Cardiac Allograft Rejection Based on Bioinformatics Analysis

Identification and Functional Prediction of Long Non-Coding RNAs in Dilated Cardiomyopathy by Bioinformatics Analysis

Upregulated Expression of Cardiac Ankyrin Repeat Protein in Human Failing Hearts Due to Arrhythmogenic Right Ventricular Cardiomyopathy.

Clinical Study of Arrhythmogenic Right Ventricular Cardiomyopathy

Proteomic Analysis Reveals Significant Elevation of Heat Shock Protein 70 in Patients with Chronic Heart Failure Due to Arrhythmogenic Right Ventricular Cardiomyopathy

Advances in Research of Arrhythmogenic Right Ventricular Cardiomyopathy

Mining of Potential Biomarkers and Pathway in Valvular Atrial Fibrillation (VAF) via Systematic Screening of Gene Coexpression Network

Comparing the global mRNA expression profile of human atrial and ventricular myocardium with high-density oligonucleotide arrays

Novel plasma biomarkers predicting biventricular involvement in arrhythmogenic right ventricular cardiomyopathy

Potential Markers for Diagnosis

Differential Gene Expression in Peripheral Blood Mononuclear Cells from Chronic Heart Failure Patients and Healthy Controls

Enhancing Arrhythmogenic Right Ventricular Cardiomyopathy Detection and Risk Stratification: Insights from Advanced Echocardiographic Techniques

Screening and Identification of Genes in Myocardial Tissue of Fetus with Ventricular Septal Defect by Using Human Genome Microarray

Distinct microRNA expression signatures in human right atrial and ventricular myocardium

Novel Algorithm for Diagnosis of Arrhythmogenic Cardiomyopathy and Dilated Cardiomyopathy: Key Gene Expression Profiling Using Machine Learning

Analysis of Potential Roles of Combinatorial Microrna Regulation in Occurrence of Valvular Heart Disease with Atrial Fibrillation Based on Computational Evidences.

Identification of the Difference in the Pathogenesis in Heart Failure Arising from Different Etiologies Using a Microarray Dataset.

Identification of potential biomarkers and candidate small- molecule drugs for heart failure via comprehensive gene microarray analysis

Bioinformatics Analysis of Sex Differences in Arrhythmogenic Right Ventricular Cardiomyopathy

Construction of Prediction Model for Atrial Fibrillation with Valvular Heart Disease Based on Machine Learning